Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Next revision		Previous revision
ad [2023/07/03 15:34] – created - external edit 127.0.0.1ad [2024/10/14 00:27] (current) – [Alzheimer's Disease and Mild Cognitive Impairment] sflitman
Line 4: Line 4:
  
 ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^ ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^
-| Mild to Moderate AD |  Novel Regenerative Injection  |  II  |  Yes  |  33%  |  26 weeks  |  26 weeks  |  +| MCI and Mild AD |  Anti-Tau Vaccine  |  II  |  Yes  |  33%  |  54 weeks  |  Anticipated  |  
-| MCI and Mild AD |  Filamin A Normalizer  |  III  |  Yes  |  50%  | 1 year  |  Anticipated  |+| MCI and Mild AD |  Anti-Tau Intravenous Antibody  |  II  |  Yes  |  50%  |  12 weeks  |  No  | 
  
 Also see [[imaging|Imaging]]. Also see [[imaging|Imaging]].

Trace:

Print/export
QR Code
QR Code ad (generated for current page)